BRAF and melanoma: Western blotting demonstrated the expected molecular signature of Hsp90 inhibition in both melanoma cell lines as shown by depletion of the client proteins CRAF, BRAF and CDK4 and induction of Hsp70 following exposure to 17-AAG, thus confirming inhibition of Hsp90 under the conditions used in our experiments (Figure 1A, top panel).